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Objective: Pseudoaneurysms are characterized by extravascular circulation and therefore may lead to an activation of the
coagulation cascade. We investigated d-dimer levels in patients with and without postcatheterization femoral pseudo-
aneurysms and hypothesized that d-dimer levels correlate with the presence of pseudoaneurysms at the vascular access site.
Methods: Patients with clinical suspected groin pseudoaneurysms after transluminal procedures were eligible. We
compared prospectively-collected laboratory values of quantitative d-dimer testing in patients with and without
pseudoaneurysms as assessed by color-coded duplex sonography. Furthermore, we measured the peak systolic velocity at
the arterial fistula of each pseudoaneurysm.
Results: In 48 (40%) of 120 consecutive patients, a pseudoaneurysm was found. The level of d-dimer values was
significantly higher in patients with postcatheterization femoral pseudoaneurysms compared with controls (1.9 g/mL
[interquartile range (IQR), 1.34-2.78 g/mL] vs 0.8 g/mL [IQR, 0.53-1.14 g/mL]; P < .001). Values of d-dimer
below 0.67 g/mL have been calculated with a sensitivity of 94% (87%-100%), a specificity of 38% (27%-50%), a positive
predictive value of 50% (40%-60%), a negative predictive value of 90% (82%-99%), and a likelihood ratio of 1.52
(1.25-1.85) with regard to the presence of pseudoaneurysms. We also found a significant correlation of the peak systolic
velocity at the arterial fistula and increasing d-dimer levels (r  0.98, P < .0001).
Conclusion: We found a significantly higher level of d-dimer values in patients with femoral pseudoaneurysms at the
vascular access site. Therefore, d-dimer levels could be a potential serological marker in the diagnosis of pseudoaneurysms.
A confirmation is warranted in a larger patient sample. ( J Vasc Surg 2010;52:383-7.)Arterial puncture for intra-arterial angiography or in-
terventional procedures carries a considerable risk of access
site complications.1,2 The incidence of hematoma, pseudoaneu-
rysms, or ateriovenous (AV)-fistulas has been estimated to
occur in up to 9% of all procedures.2-6 In particular, with
the increasing use of aggressive antithrombotic substances
such as glycoprotein IIb/IIIa antagonists, the frequency of
complications at the vascular access site tends to increase.
Therefore, screening of the vascular access site after percu-
taneous transluminal procedures is frequently done after
percutaneous procedures. The most common technique in
the assessment of the puncture site is, besides physical
examination, color-coded duplex sonography, which is cur-
rently considered the diagnostic approach of choice.7-11
Despite the widespread availability of color-coded duplex
sonography, it would be clinically and, furthermore, eco-
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means of blood testing in advance of sonography.
A low platelet count seems to be significantly linked
and positively predictive to the occurrence of iatrogenic
pseudoaneurysms at the vascular access site.6 Pseudoaneu-
rysms at the vascular access site lead to extravascular circu-
lation and may, therefore, plausibly activate parts of the
coagulation cascade. Therefore, the investigation of the
predictive capability of different coagulation parameters is
clearly justified.
It has been shown that d-dimer plasma levels can be
used as a negative predictive parameter in ruling out several
conditions in vascular medicine, such as venous thrombo-
embolism or acute aortic dissection.12,13 Overall, d-dimer
is a widely used biomarker of endogenous fibrinolysis, and
elevated levels may be found in patients with extravascular
circulation. However, the role of d-dimer levels with regard
to the occurrence of pseudoaneurysms at the vascular access
site has not been investigated so far.
We hypothesize that elevated d-dimer levels correlate
with the presence of pseudoaneurysm at the vascular access
site.
METHODS
Study design and patient recruitment. The study
was designed as a prospective case-control study. All con-
secutive patients with clinical suspected postpuncture groin
pseudoaneurysms who had been referred to duplex scan-
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tertiary care university hospital from January 2008 to Oc-
tober 2008 were eligible. The study was approved by the
local ethics committee, and all patients provided written
informed consent.
Clinical assessment of the access site. The referring
physician assessed the groin clinically and noted if indura-
tions, systolic bruits, local pain, and swelling in combina-
tion with or without pulsation were present. The result of
this judgement decided whether the patient had been re-
ferred or not.
Exclusion criteria. Patients with recently diagnosed
pulmonary embolism or deep venous thrombosis were not
eligible for this study. Patients with active malignancy as
well as patients with renal failure were not suitable for this
study. Patients with apparent infections and markedly ele-
vated C-reactive protein (CRP) levels (1.5 mg/dL) were
also excluded.
Patient data. The medical history and data from phys-
ical examination from each patient was recorded. Special
attention was brought to antiplatelet therapy and anticoag-
ulant regimen before and during the intervention. The
exact location of the arterial puncture was recorded as in the
common femoral artery (CFA), superficial femoral artery
(SFA), or profound femoral artery (PFA).
Laboratory parameters. All patients underwent rou-
tine laboratory investigations prior to and 24 hours after
percutaneous endovascular procedures. The laboratory
analysis preprocedure included complete blood cell count,
global coagulation tests, glycated hemoglobin (Hb1Ac),
low-density-lipoprotein (LDL) and high-density-lipopro-
tein (HDL) cholesterol, serum triglycerides, liver enzymes,
serum creatinine, high-sensitivity C-reactive protein, and
fibrinogen. The postprocedure analysis included serum cre-
atinine and complete blood cell count. Plasma d-dimer
levels were only assessed in samples obtained 24 hours after
the percutaneous procedure by an enzyme-linked immuno-
assay (STA Liatest D-dimer; Diagnostica Stago, Asnieres,
France). In our institution, the cutoff value is 0.5 g/mL.
Color-coded duplex sonography of the access site
and follow-up. All patients underwent color-coded du-
plex sonography 24 hours after the intervention. Duplex
examinations were performed on an Acuson SequoiaM512
with an 8-MHZ linear array probe (Acuson, Mountain
View, Calif). The arterial access was visualized from the
external iliac artery down to the SFA, including the femoral
bifurcation and the profound femoral artery. Scans were
obtained in transversal and in longitudinal views. A pseu-
doaneurysm was defined as localized extravascular jets con-
nected to the artery by an iatrogenic fistula. Once a pseu-
doaneurysm was detected, the maximum diameter and the
peak systolic velocity at the arterial fistula were recorded.
Clinically, patients were followed until hospital discharge
for the occurrence of any adverse events.
Statistical analysis. Continuous data are presented as
the median and the interquartile range (IQR; range from
the 25th to the 75th percentile); discrete data are given as
counts and percentages. Univariate comparisons betweenthe study groups were made by chi square tests, exact test,
and unpaired t tests, as appropriate. For univariate analyses,
Spearman correlation coefficients were used. A multivariate
binary logistic regression model was applied to assess the
association between the treatment groups and the study
endpoints and to adjust for possible confounders. D-dimer
levels were categorized into quartiles, and the lowest quar-
tile was used as the reference quartile for further analysis,
respectively. Results of the logistic regression model were
given as the odds ratio (OR) and the 95% confidence
interval (95% CI). A P value .05 was considered statisti-
cally significant. Calculations were performed with Stata
(release 8.0; StataCorp, College Station, Tex) and SPSS for
Windows (version 16.0; SPSS Inc, Chicago, Ill).
RESULTS
Baseline characteristics. Within the study period,
120 consecutive patients who met study inclusion criteria
were referred to our sonography laboratory for color-coded
duplex sonography of the vascular access site at the discre-
tion of the treating physician. A pseudoaneurysm was iden-
tified in 48 (40%) of these clinical preselected patients. In
72 patients (60%), duplex sonography revealed negative
results with regard to the presence of femoral pseudoaneu-
rysms at the puncture site (control group). In 28 (23%)
patients, the protocol-driven sonography revealed a hema-
toma at the vascular access point; no AV-fistula had been
noted. None of the patients with hematomawere in need of
transfusion; therefore, we initially coded them as clinically
insignificant. From the statistical point of view, the patients
with hematoma were virtually similar to patients without
any sonographic finding. Therefore, we decided summarize
those patients as the control group.
There was no significant difference between the two
groups in age, gender, and traditional cardiovascular risk
factors such as hypercholesterolemia, arterial hypertension,
and diabetes mellitus. There were slightly more smokers in
the control group than in the pseudoaneurysm group (42%
vs 36%, P .05). In the pseudoaneurysm group, 29 (60%)
patients had a history of peripheral artery disease, and 40
(85%) patients had a history coronary artery disease com-
pared with 41 (87%) and 62 (86%), respectively, in the
control group (P  .12).There was no difference between
the two groups in antiplatelet treatment (Table I).
Course of patients with pseudoaneurysm. As re-
ported, we found 48 patients with pseudoaneurysms at the
vascular access site. All pseudoaneurysms were successfully
treated by percutaneous injection of thrombin under sono-
graphical control. Two patients (4%) presented with partial
reperfusion at the former pseudoaneurysm neck. These
patients underwent sonographically guided compression
therapy over 30 and 42 minutes, respectively. Thereafter,
the pseudoaneurysm appeared to be completely occluded.
Percutaneous transluminal procedures. In 99% of
all procedures, a 6F sheath was used, and all procedures
were performed using transfemoral access. In our study
sample, 23 patients underwent a percutaneous coronary
intervention. The remaining 97 (81%) patients were re-
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ripheral arteries. Thus, there were no differences between
the two groups in sheath size and access route. Twelve
(17%) patients in the control group received more than
5000 IU heparin during the procedure, compared with two
(4%) in the pseudoaneurysm group (P  .04). All other
patients received 5000 IU heparin at the highest. Regard-
ing the use of a vascular sealing device (Angio-Seal [St. Jude
Medical Inc, St. Paul, Minn] was used only), there was no
significant difference among the two study populations
(Table II).
Coagulation activation. In univariate comparison,
patients with iatrogenic pseudoaneurysms showed statisti-
cally significant higher d-dimer levels as controls (1.9
g/mL [IQR, 1.34-2.78 g/mL] vs 0.8 g/mL [IQR,
0.53-1.14 g/mL]; P  .001]; Fig 1). After adjusting for
possible confounding factors, this association remained
statistically significant. The multivariate model is displayed
in Table III.
The displayed reference category (d-dimer level of 0.67
g/mL) that can be obtained in Table III has been calcu-
lated with a sensitivity of 94% (87%-100%), a specificity of
38% (27%-50%), a positive predictive value of 50% (40%-
Table I. Baseline characteristics of study population
Pseudoaneurysm
n  48
Controls
n  72 P value
Age, yrs (IQR) 77 (57-78) 70 (64-77) .12
Male gender 20 (42%) 37 (51%) .3
Smoking 17 (36%) 30 (42%) .05
Hypercholerstrolemia 45 (94%) 66 (92%) .7
Hypertension 44 (92%) 60 (83%) .19
Diabetes mellitus 22 (46%) 42 (58%) .11
Antiplatelet therapy
Aspirin or clopidogrel 8 (17%) 21 (29%) .12
Aspirin and clopidogrel 40 (83%) 51 (71%)
Peripheral artery disease 29 (60%) 41 (57%) .7
Coronary artery disease 40 (85%) 62 (86%) .8
IQR, Interquartile range.
Table II. Percutaneous transluminal procedure details of
patients and controls
Pseudoaneurysm
n  48
Controls
n  72 P value
Closing device 20 (42%) 37 (51%) .3
Sheath size
6F 47 (98%) 72 (100%) .22
8F 1 (2%) 0 (—)
Heparin
up to 5000 IU 46 (96%) 60 (83%) .04
5000 IU 2 (4%) 12 (17%)
D-dimer, g/mL
(IQR) 1.9 (1.34-2.78) 0.8 (0.53-1.14) .001
Platelet count,
G/L (IQR) 172 (163-192) 274 (221-309) .001
IQR, Interquartile range.60%), a negative predictive value of 90% (82%-99%), and alikelihood ratio of 1.52 (1.25-1.85) with regard to the
presence of pseudoaneurysms.
All patients in the pseudoaneurysm group had a platelet
count of less than 200 G/L (172 G/L [IQR, 163-192
G/L]) compared with the control group with a median
platelet count of 274 G/L ([IQR, 221-309 G/L]; P 
.0001).
Pseudoaneurysms. The identified pseudoaneurysms
measured 19 mm (median; IQR, 15-25 mm) in the maxi-
mum diameter. Univariate comparison revealed a signifi-
cant association of pseudoaneurysm size and increasing
quartiles of d-dimer levels (P  .02). Further testing
showed a significant correlation of peak systolic velocity at
the arterial fistula and increasing d-dimer levels (r  0.98,
Fig 1. Box plots of D-dimer levels in controls and patients with
pseudoaneurysms. Box bottom marks the 25th percentile, the line
within marks the median, and the box top marks the 75th percen-
tile; the bottom and top of the vertical lines mark the 5th and 95th
percentiles, respectively.
Table III. Multinominal logistic regression model
according to quartiles of d-dimer
Odds ratio
95% Confidence
interval P value
D-dimer quartile I
(below 0.67 g/mL) 1.0 — —
D-dimer quartile II
(0.67 to 1.06 g/mL) 7.4 2.0-27.7 .003
D-dimer quartile III
(1.06 to 1.8 g/mL) 22.4 5.4-92.8 .001
D-dimer quartile IV
(above 1.8 g/mL) 53.0 10.2-276,6 .001
— denotes reference category.
Model adjusted for heparin, diabetes mellitus, antiplatelet medication, route
of puncture, and platelet count.P  .0001; Fig 2).
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Our results clearly demonstrate a relation between co-
agulation activation and the presence of femoral pseudoa-
neurysms after percutaneous transluminal procedures.
Patients with confirmed pseudoaneurysm-assessed by
color-coded duplex sonography had significantly higher
d-dimer levels compared with patients without pseudoan-
eurysms. This association remained statistically significant
after adjustment for possible confounding and predispos-
ing factors. Noteworthy, we found a strong association
between a low platelet count (below 200 G/L) and the
presence of pseudoaneurysms. This confirmed data from a
previous investigation conducted at our facility.6 Interest-
ingly, patients in the control group received a higher
amount of heparin during the procedure. This seems to be
contradictory to the clinical presentation and might be
explained by the rather small sample size.
Pseudoaneurysm as a result of iatrogenic vascular injury
is defined as an extravascular jet into the surrounding tissue.
The repeated contact to coagulation promoting subendo-
thelial structures, based on the typically in pseudoaneurysm-
fistulas detectable to-and-fro flow-pattern may lead to this
coagulation activation displayed by elevated d-dimer levels
as biomarker of fibrin turnover. Furthermore, a dynamic
process in the aneurysmal sac may promote hemostatic
activation as well.14-16 There was a slightly significant asso-
ciation of d-dimer levels and pseudoaneurysm size, which
may partly be explained by the higher impact of different
hemodynamic phenomenon. Consistently, we found a sig-
nificant correlation between the peak systolic velocity at the
fistula and the d-dimer levels, which reflects the partial
activation of hemostasis by means of shear stress as respon-
sible hemodynamic phenomenon.
In addition, d-dimer levels showed a gradual and inde-
pendent association with risk for femoral pseudoaneurysm
Fig 2. Correlation of d-dimer levels and the peak systolic velocity
at the pseudoaneurysm fistula.after percutaneous transluminal procedures. Patients withd-dimer levels above the highest quartile had a 53-fold
increased risk for the presence of femoral pseudoaneurysm
compared with patients with d-dimer below the lowest
quartile. Also, the impressive negative predictive value of
virtually quite normal d-dimer levels could imply a more
stepwise diagnostic approach for the future. The first diag-
nostic step in patients suspicious of suffering a postpunc-
ture pseudoaneurysm at the access site could be a d-dimer
testing. If the value exceeds a certain level, an additional
duplex sonography could follow the laboratory assessment.
This suggested approach is clinically important due to
various reasons. First, it is less expensive to measure d-
dimer levels and probably saves money on a needless sonog-
raphy. Second, it saves time carrying just those patients to
the sonography ward who are deeply at risk instead of
suspicious for pseudoaneurysms at the vascular access site.
We are aware of certain limitations of our study. Our
study population consisted of clinical preselected patients
and was conducted as a single-center, case-control study
with a small sample size. This design might not be appro-
priate to establish a risk score for the diagnosis of pseudoa-
neurysms. Prospective cohort studies with a larger sample
size are needed to gain more precise data. However, our
results may point into a certain direction, whereas direct
conclusions are not appropriate and warrant further inves-
tigations in larger patient series.
D-dimer allows an efficient assessment of coagulation
activation, and our study was the fist to show the relation
between coagulation activation and the risk for groin
pseudoaneurysms after percutaneous transluminal pro-
cedures. These findings may lead to new clinical impli-
cations.
We conclude that, in case of femoral pseudoaneu-
rysms, there is a certain amount of hemostatic activation
displayed by elevated levels of d-dimer. The convincing
level of the presented negative predictive value of d-
dimer levels up to 0.67 g/mL could be used to serve as
a surrogate in ruling out pseudoaneurysms at the vascu-
lar access site. A confirmation is warranted in a larger
patient sample.
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